Skip to main content
OpenTrials
Completed

NCT Number: NCT01786746

Adapting Cognitive Behavioral Therapy (CBT) for Chinese Americans

The goals of this study were to a) test whether cognitive behavioral therapy (CBT) is effective in treating depressed Chinese Americans, b) to develop and test the effectiveness of culturally adapt CBT, and c) to test the differential outcomes of the two treatments.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Claremont McKenna College

Claremont, California, 91711, United States

About this study

It is now known that ethnic minorities are less likely to receive quality health services and evidence worse treatment outcomes when compared with other groups (IOM, 1999; USDHHS, 2001). Moreover, there continues to be a shortage of systematic investigations examining the efficacy of evidence-based treatments (EBTs) with ethnic minorities, especially among Chinese Americans. Developing interventions that are both empirically grounded and that are culturally sensitive and compatible with Chinese culture is one promising strategy that may improve treatment outcomes for this understudied group. The goal of this study is to culturally adapt a cognitive-behavioral therapy manual for use with depressed Chinese American patients. This study will be among the first to develop a culturally adapted EBT for use with this ethnic group and will involve three study phases. Phase I of the study will focus on modifying and refining a CBT intervention protocol into a manualized treatment for Chinese Americans. Phase two involves a randomized controlled trial (RCT) comparing the effects of the culturally adapted CBT treatment manual with nonadapted CBT. Phase three will involve further refinement of the treatment manual, data analysis, and report writing. Patients will be recruited from an ethnic-specific mental health center that specializes in treating Asian American clientele to participate in the study. Patients will be randomly assigned to either the adapted CBT treatment or the nonadapted CBT treatment. Moreover, feedback from patients and therapists in both conditions will be used to further refine the new treatment manual, provide valuable information about salient issues in treating depressed Chinese Americans, and will provide initial estimates of treatment parameters that will be used in preparing a larger R01 proposal to further test the adapted intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • depression, Chinese American

Exclusion criteria

  • bipolar, psychotic disorder, primary substance abuse problem, severe medical conditions that induce depression

Treatment and study plan

Cognitive behavioral therapy

Behavioral

cognitive behavioral therapy. 12 sessions.

culturally adapted cognitive behavioral therapy

Behavioral

culturally adapted cognitive behavioral therapy for Chinese Americans. 12 sessions.

Primary outcomes

  1. Hamilton Depression Rating Scale (Change is being assessed)

    Time frame: baseline, session 4, 8, 12, and three months follow-up

    most commonly used depression rating scale

Sponsors and collaborators

Lead sponsor

Claremont McKenna College

Other

Collaborators

  • University of California, Los Angeles

Registry information

Official study title

Cognitive Behavioral Therapy (CBT)

Important dates

Study start
2007
Primary completion
2011
Study completion
2011
First posted
Feb 8, 2013
Registry last updated
Feb 8, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.